Remi Gaston-dreyfus - Net Worth and Insider Trading

Remi Gaston-dreyfus Net Worth

The estimated net worth of Remi Gaston-dreyfus is at least $19 dollars as of 2024-12-01. Remi Gaston-dreyfus is the Director, 10% Owner of Bionik Laboratories Corp and owns about 1,876,127 shares of Bionik Laboratories Corp (BNKL) stock worth over $19. Details can be seen in Remi Gaston-dreyfus's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Remi Gaston-dreyfus has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Remi Gaston-dreyfus

To

Remi Gaston-dreyfus Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Remi Gaston-dreyfus owns 1 companies in total, including Bionik Laboratories Corp (BNKL) .

Click here to see the complete history of Remi Gaston-dreyfus’s form 4 insider trades.

Insider Ownership Summary of Remi Gaston-dreyfus

Ticker Comapny Transaction Date Type of Owner
BNKL Bionik Laboratories Corp 2023-06-09 director & 10 percent owner

Remi Gaston-dreyfus Latest Holdings Summary

Remi Gaston-dreyfus currently owns a total of 1 stock. Remi Gaston-dreyfus owns 1,876,127 shares of Bionik Laboratories Corp (BNKL) as of June 9, 2023, with a value of $19.

Latest Holdings of Remi Gaston-dreyfus

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BNKL Bionik Laboratories Corp 2023-06-09 1,876,127 0.00 19

Holding Weightings of Remi Gaston-dreyfus


Remi Gaston-dreyfus Form 4 Trading Tracker

According to the SEC Form 4 filings, Remi Gaston-dreyfus has made a total of 1 transactions in Bionik Laboratories Corp (BNKL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bionik Laboratories Corp is the acquisition of 180,555 shares on June 9, 2023, which cost Remi Gaston-dreyfus around $108,333.

Insider Trading History of Remi Gaston-dreyfus

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Remi Gaston-dreyfus Trading Performance

GuruFocus tracks the stock performance after each of Remi Gaston-dreyfus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Remi Gaston-dreyfus is -47.24%. GuruFocus also compares Remi Gaston-dreyfus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Remi Gaston-dreyfus within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Remi Gaston-dreyfus's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Remi Gaston-dreyfus

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -21.26 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -24.15 LIMIT LIMIT LIMIT LIMIT LIMIT

Remi Gaston-dreyfus Ownership Network

Ownership Network List of Remi Gaston-dreyfus

No Data

Ownership Network Relation of Remi Gaston-dreyfus

Insider Network Chart

Remi Gaston-dreyfus Owned Company Details

What does Bionik Laboratories Corp do?

Who are the key executives at Bionik Laboratories Corp?

Remi Gaston-dreyfus is the director & 10 percent owner of Bionik Laboratories Corp. Other key executives at Bionik Laboratories Corp include director & Chairman Andre-jacques Auberton-herve , Executive Vice President & CFO Daniel Gonsalves , and See Remarks Loren W. Wass .

Bionik Laboratories Corp (BNKL) Insider Trades Summary

Over the past 18 months, Remi Gaston-dreyfus made 1 insider transaction in Bionik Laboratories Corp (BNKL) with a net purchase of 180,555. Other recent insider transactions involving Bionik Laboratories Corp (BNKL) include a net purchase of 650,000 shares made by Andre-jacques Auberton-herve , a net purchase of 180,555 shares made by Charles Matine ,

In summary, during the past 3 months, insiders sold 0 shares of Bionik Laboratories Corp (BNKL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bionik Laboratories Corp (BNKL) were sold and 1,011,110 shares were bought by its insiders, resulting in a net purchase of 1,011,110 shares.

Bionik Laboratories Corp (BNKL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bionik Laboratories Corp Insider Transactions

No Available Data

Remi Gaston-dreyfus Mailing Address

Above is the net worth, insider trading, and ownership report for Remi Gaston-dreyfus. You might contact Remi Gaston-dreyfus via mailing address: 46 Rue Pierre Charron, Paris I0 75008.

Discussions on Remi Gaston-dreyfus

No discussions yet.